GPT and metabolic dysfunction-associated steatotic liver disease: At the endpoint, in both cases, reductions in ALT and AST were observed, which confirm this measure’s beneficial effect on the state of patients with NAFLD and shows that this type of intervention could be helpful in managing NAFLD [64].